Interleukin-1 alpha, soluble interleukin-2 receptor, and IgG concentrations in cystic fibrosis treated with prednisolone.
about
Oral steroids for long-term use in cystic fibrosisAppetite stimulants for people with cystic fibrosisOral steroids for long-term use in cystic fibrosisOral steroids for long-term use in cystic fibrosisExacerbations in cystic fibrosis: 2 . prevention.Oral steroids for cystic fibrosis.The role of inhaled corticosteroids in the management of cystic fibrosis.Towards the pharmacogenomics of cystic fibrosis.Randomised controlled trial of inhaled corticosteroids (fluticasone propionate) in cystic fibrosis.Potential of anti-inflammatory treatment for cystic fibrosis lung disease.Antiinflammatory therapies for cystic fibrosis: past, present, and future.Systematic Review of the Toxicity of Long-Course Oral Corticosteroids in Children.Cystic fibrosis pulmonary guidelines: chronic medications for maintenance of lung health.Managing cystic fibrosis: strategies that increase life expectancy and improve quality of life.Cystic fibrosis pulmonary guidelines. Chronic medications for maintenance of lung health.Down-regulation of cytokine-induced interleukin-8 requires inhibition of p38 mitogen-activated protein kinase (MAPK) via MAPK phosphatase 1-dependent and -independent mechanisms.The role of corticosteroids in respiratory diseases of children.Effect of oral glycine on the clinical, spirometric and inflammatory status in subjects with cystic fibrosis: a pilot randomized trial.Role of corticosteroids in cystic fibrosis lung disease.Controlled Trial of Inhaled Budesonide in Patients with Cystic Fibrosis and Chronic BronchopulmonaryPseudomonas aeruginosaInfection
P2860
Q24187156-629464C5-9268-4EC4-8E81-B85AB4C3CEE9Q24194798-ADC35485-6631-4055-9E1B-CF512B33CB93Q24201834-D403167A-1B27-48AF-AA98-465170FB47FAQ24236222-CC1C9D8D-FC70-4FD5-88AD-1DD12DB8ED3DQ30480308-5716593C-34BF-4625-9CC5-FC4D2CE9F487Q33909503-57F7DD42-2575-47CD-9107-0B6DF8656F37Q34131911-DBF2BD8A-CE3C-4430-B28F-3C362CA8AF76Q34609152-7B36215F-F8B2-4285-A3BE-D344578E8170Q35256369-2D3C4CE1-1D96-4D07-9B4A-F78AB1CBB49CQ35557381-A62E1596-BACF-4B28-8A08-A2D61A55303AQ36174470-4C72AF96-DB20-4431-B688-5C143757F86DQ36261095-252F161F-E8A1-48DE-AED1-C12DFFB8EEA8Q36924692-61DD8447-C753-4D21-AEBF-244948505D3BQ37844338-B3D13EC0-848C-496B-9ACB-A2D388DA96C2Q38094297-BBD95BDD-B147-47D3-B28B-4A2DA8FA93A7Q39567122-C4A4BC69-24B1-45A5-8B65-44CAA79DECCDQ41151318-01F2D25A-632E-48D1-80B8-E989BBCC3FE0Q47136819-7DDDA68C-0B99-47BE-9BCE-4D2D5663451AQ55520869-9E72086C-6BAB-42A8-A735-AC6A82FEABFDQ57638396-CBE755FF-7C22-49C2-8F5B-90BAF5965C25
P2860
Interleukin-1 alpha, soluble interleukin-2 receptor, and IgG concentrations in cystic fibrosis treated with prednisolone.
description
1994 nî lūn-bûn
@nan
1994 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Interleukin-1 alpha, soluble i ...... sis treated with prednisolone.
@ast
Interleukin-1 alpha, soluble i ...... sis treated with prednisolone.
@en
type
label
Interleukin-1 alpha, soluble i ...... sis treated with prednisolone.
@ast
Interleukin-1 alpha, soluble i ...... sis treated with prednisolone.
@en
prefLabel
Interleukin-1 alpha, soluble i ...... sis treated with prednisolone.
@ast
Interleukin-1 alpha, soluble i ...... sis treated with prednisolone.
@en
P2093
P2860
P356
P1476
Interleukin-1 alpha, soluble i ...... sis treated with prednisolone.
@en
P2093
P2860
P356
10.1136/ADC.71.1.35
P407
P577
1994-07-01T00:00:00Z